We have located links that may give you full text access.
Side-Chain Modified [ 99m Tc]Tc-DT1 Mimics: A Comparative Study in NTS 1 R-Positive Models.
International Journal of Molecular Sciences 2023 October 25
Radiolabeled neurotensin analogs have been developed as candidates for theranostic use against neurotensin subtype 1 receptor (NTS1 R)-expressing cancer. However, their fast degradation by two major peptidases, neprilysin (NEP) and angiotensin-converting enzyme (ACE), has hitherto limited clinical success. We have recently shown that palmitoylation at the ε -amine of Lys7 in [99m Tc]Tc-[Lys7 ]DT1 (DT1, N4 -Gly-Arg-Arg-Pro-Tyr-Ile-Leu-OH, N4 = 6-(carboxy)-1,4,8,11-tetraazaundecane) led to the fully stabilized [99m Tc]Tc-DT9 analog, displaying high uptake in human pancreatic cancer AsPC-1 xenografts but unfavorable pharmacokinetics in mice. Aiming to improve the in vivo stability of [99m Tc]Tc-DT1 without compromising pharmacokinetics, we now introduce three new [99m Tc]Tc-DT1 mimics, carrying different pendant groups at the ε -amine of Lys7 : MPBA (4-(4-methylphenyl)butyric acid)-[99m Tc]Tc-DT10; MPBA via a PEG4-linker-[99m Tc]Tc-DT11; or a hydrophilic PEG6 chain-[99m Tc]Tc-DT12. The impact of these modifications on receptor affinity and internalization was studied in NTS1 R-positive cells. The effects on stability and AsPC-1 tumor uptake were assessed in mice without or during NEP/ACE inhibition. Unlike [99m Tc]Tc-DT10, the longer-chain modified [99m Tc]Tc-DT11 and [99m Tc]Tc-DT12 were significantly stabilized in vivo, resulting in markedly improved tumor uptake compared to [99m Tc]Tc-DT1. [99m Tc]Tc-DT11 was found to achieve the highest AsPC-1 tumor values and good pharmacokinetics, either without or during NEP inhibition, qualifying for further validation in patients with NTS1 R-positive tumors using SPECT/CT.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app